MEGAN CASSELMAN: Open Payments
NPI 1528619525 · MIDLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$587 in 46 payments from 9 companies in 2025. Trend: 2023 $553 · 2024 $567 · 2025 $587
Food & beverage: $587
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 23 | $177 |
| Lilly USA, LLC | 5 | $94 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $70 |
| Novo Nordisk Inc | 4 | $62 |
| Sumitomo Pharma America, Inc. | 2 | $49 |
| GlaxoSmithKline, LLC. | 3 | $43 |
| PFIZER INC. | 2 | $40 |
| Exact Sciences Corporation | 2 | $32 |
| Dexcom, Inc. | 1 | $20 |
Products named: OTEZLA, JARDIANCE, MOUNJARO, EVENITY, GEMTESA, TRELEGY ELLIPTA, Rybelsus, Cologuard Collection Kit.
Industry payments across TX — which companies pay providers there.
